Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0540 Transporter Info | ||||
Gene Name | ATP12A | ||||
Transporter Name | Potassium-transporting ATPase alpha chain 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ATP12A gene in melanoma condition | [1] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of ATP12A gene in melanoma condition, which leads to an increased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of ATP12A gene in medulloblastoma condition | [2] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to repress the transcription of ATP12A gene in medulloblastoma condition, which leads to a decreased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ATP12A gene in coronary artery disease (CAD) condition | [3] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 21 (TCF21) has been reported to bind to the transcription of ATP12A gene in coronary artery disease (CAD) condition, which leads to a affected expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ATP12A gene | [4] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the ATP12A gene, which in turn affects the expression or function of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ATP12A gene | [5] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the ATP12A gene, which in turn affects the expression or function of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ATP12A gene in prostate cancer condition | [6] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of ATP12A gene in prostate cancer condition, which leads to an affected expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ATP12A gene | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of ATP12A gene in . condition, which leads to a affected expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of ATP12A gene in embryonic stem cell condition | [8] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) has been reported to repress the transcription of ATP12A gene in embryonic stem cell condition, which leads to a decreased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to ATP12A gene | [9] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the ATP12A gene, which in turn affects the expression or function of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
NFKB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of ATP12A gene in health condition | [10] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Renal medulla | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Mouse renal medulla collecting duct cells (mIMCD-3) | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to repress the transcription of ATP12A gene in health condition, which leads to a decreased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
RELA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of ATP12A gene in health condition | [10] | ||||
TF Protein Name |
Transcription factor p65 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Renal medulla | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Mouse renal medulla collecting duct cells (mIMCD-3) | |||||
Detailed Description |
Transcription factor p65 (RELA) has been reported to repress the transcription of ATP12A gene in health condition, which leads to a decreased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to ATP12A gene in megakaryocytes condition | [11] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of ATP12A gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
SMAD3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ATP12A gene in hESCs condition | [12] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 3 (SMAD3) has been reported to activate the transcription of ATP12A gene in human embryonic stem cells (hESCs) condition, which leads to an increased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of ATP12A gene in health condition | [12] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of ATP12A gene in health condition, which leads to an increased expression of the drug transporter Potassium-transporting ATPase alpha chain 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.